| BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk |
NCT01542060: Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus |
|
|
| Completed | N/A | 298 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 12/04 | 12/04 | | |
NCT01536652: Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes |
|
|
| Completed | N/A | 4994 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 11/06 | 11/06 | | |
NCT01536600: Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes |
|
|
| Completed | N/A | 33010 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 12/06 | 12/06 | | |
NCT01536639: Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes |
|
|
| Completed | N/A | 454 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 12/06 | 12/06 | | |
NCT01542424: An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus |
|
|
| Completed | N/A | 1889 | RoW | biphasic insulin aspart 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 12/06 | 12/06 | | |
NCT01536613: Post Marketing Surveillance Study of Biphasic Insulin Aspart 30 |
|
|
| Completed | N/A | 5346 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 02/07 | 02/07 | | |
NCT01548235: Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment |
|
|
| Completed | N/A | 423 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 04/07 | 04/07 | | |
NCT01536626: Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands |
|
|
| Completed | N/A | 211 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 04/07 | 04/07 | | |
NCT01565733: Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes |
|
|
| Completed | N/A | 2223 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 07/07 | 07/07 | | |
NCT00715663: Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes |
|
|
| Completed | N/A | 1584 | RoW | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2, Delivery Systems | 12/07 | 12/07 | | |
| Completed | N/A | 1155 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/08 | 01/08 | | |
NCT00665093: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 1569 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/08 | 01/08 | | |
NCT00657319: Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins |
|
|
| Completed | N/A | 3495 | Europe | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/08 | 04/08 | | |
Start, NCT00696995: An Observational Study of Type 2 Diabetes in Patients ing on NovoMix® 30 Treatment |
|
|
| Completed | N/A | 509 | Europe | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 09/08 | 09/08 | | |
NCT00671008: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 400 | RoW | biphasic insulin aspart 30, NovoMix® 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/08 | 09/08 | | |
| Completed | N/A | 57610 | Japan, Canada, Europe, RoW | biphasic insulin aspart, BIASP, NovoMix 30, NovoLog Mix 70/30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 11/08 | 11/08 | | |
NCT00675493: Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30 |
|
|
| Completed | N/A | 942 | Europe | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/09 | 01/09 | | |
IMPROVE Life, NCT00696163: Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes |
|
|
| Completed | N/A | 24975 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIAsp30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/09 | 03/09 | | |
NCT00709683: Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen® |
|
|
| Completed | N/A | 216 | RoW | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 05/09 | 05/09 | | |
NCT00698269: An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment |
|
|
| Completed | N/A | 5926 | RoW | insulin detemir, Levemir®, biphasic insulin aspart 30, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
SAFE, NCT00789711: An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes |
|
|
| Completed | N/A | 3131 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
EFFECTIVE, NCT00699179: Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes |
|
|
| Completed | N/A | 2308 | RoW | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/09 | 09/09 | | |
NCT00670722: Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin |
|
|
| Completed | N/A | 6500 | Europe | insulin aspart, NovoRapid®, insulin detemir, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 12/09 | 12/09 | | |
UPGRADE, NCT00737776: Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes |
|
|
| Completed | N/A | 1068 | RoW | biphasic insulin aspart 30, NovoMix® 30, NovoLog® Mix 70/30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/10 | 01/10 | | |
NCT00834262: Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients |
|
|
| Completed | N/A | 339 | RoW | biphasic insulin aspart 30, NovoMix® 30, biphasic insulin aspart 50, biphasic insulin aspart 70 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 02/10 | 02/10 | | |
COMMIT, NCT00676741: Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin |
|
|
| Completed | N/A | 3809 | Europe | insulin aspart, NovoRapid®, biphasic insulin aspart 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 05/10 | 05/10 | | |
NCT00771680: Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes |
|
|
| Completed | N/A | 10408 | RoW | insulin detemir, biphasic insulin aspart 30, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 07/10 | 07/10 | | |
NCT00729898: Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes |
|
|
| Completed | N/A | 243 | Europe | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 09/10 | 09/10 | | |
NCT00842894: Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia |
|
|
| Completed | N/A | 3421 | RoW | insulin detemir, NN304, Levemir®, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/10 | 10/10 | | |
Mix2Mix, NCT00775736: Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin |
|
|
| Completed | N/A | 611 | Europe | biphasic insulin aspart 30, BIAsp, biphasic insulin aspart 50, biphasic insulin aspart 70 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/11 | 01/11 | | |
A1chieve, NCT00869908: Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication |
|
|
| Completed | N/A | 66726 | RoW | insulin aspart, NovoRapid®, ANA, insulin detemir, biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/11 | 03/11 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
